Dr. Keith Flaherty

Dr. Keith Flaherty is a leading cancer researcher and physician specializing in melanoma, the most serious form of skin cancer. He works at Massachusetts General Hospital and Harvard Medical School, focusing on developing targeted treatments that interrupt the molecular pathways driving melanoma growth. His research aims to improve therapies, especially for advanced cases that are resistant to standard treatments. Dr. Flaherty is also involved in clinical trials, helping bring innovative drugs from laboratory research to patient care. His work has significantly contributed to personalized cancer treatment, offering hope for better outcomes in melanoma and other cancers.